Gina C. Guzman, MD, DBIM, ALMI Second Vice President & Medical Director, Munich American Re

This presentation will provide an easy to understand approach to underwriting this complex group of disorders. It will define Myeloproliferative Disorders and the major clinical diagnoses included in this group. Diagnostic as well as prognostic factors will be covered, to help underwriters stratify risk assessment of these conditions.